The PTEN tail contains a PDZ domain, which interacts with the IP4P domain (ranging from 755 to 1606) of PREX2 and is sufficient to antagonize the PREX2-driven invasion when tested in breast cancer cells, BT549 and SUM149, and in human embryonic kidney, 293 cells12. Here, PTEN is linked to breast carcinoma.